Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kalipso Chalkidou

Showing results (91-100 of 150) with videos related to

Pageof 15
Sort By:
Pharmacoeconomics|August 23, 2014
Healthy decisions: towards uncertainty tolerance in healthcare policyJanneke P C Grutters, Marjolein B A van Asselt, Kalipso Chalkidou, et al.
BMJ Global Health|October 27, 2018
Mind the costs, too: towards better cost-effectiveness analyses of PBF programmesY-Ling Chi, Mohamed Gad, Sebastian Bauhoff, et al.
The Milbank Quarterly|June 16, 2009
Comparative effectiveness research and evidence-based health policy: experience from four countriesKalipso Chalkidou, Sean Tunis, Ruth Lopert, et al.
International Journal of Health Policy and Management|January 23, 2022
Developing a How-to-Guide for Health Technology Reassessment: "The HTR Playbook"Lesley J J Soril, Adam G Elshaug, Rosmin Esmail, et al.
Gates Open Research|October 22, 2019
How can we make better health decisions a Best Buy for all?: Commentary based on discussions at iDSI roundtable on 2 <sup>nd</sup> May 2019 London, UKNiki O'Brien, Ryan Li, Wanrudee Isaranuwatchai, et al.
European Journal of Cancer (Oxford, England : 1990)|May 29, 2021
Economic impact of avoidable cancer deaths caused by diagnostic delay during the COVID-19 pandemic: A national population-based modelling study in England, UKAdrian Gheorghe, Camille Maringe, James Spice, et al.
Global Heart|February 19, 2015
Priority-setting institutions in health: recommendations from a center for global development working groupAmanda Glassman, Kalipso Chalkidou, Ursula Giedion, et al.
The Lancet. Oncology|February 19, 2014
Evidence-informed frameworks for cost-effective cancer care and prevention in low, middle, and high-income countriesKalipso Chalkidou, Patricio Marquez, Preet K Dhillon, et al.
Frontiers in Public Health|September 13, 2021
An Introduction to the Main Types of Economic Evaluations Used for Informing Priority Setting and Resource Allocation in Healthcare: Key Features, Uses, and LimitationsHugo C Turner, Rachel A Archer, Laura E Downey, et al.
Cost Effectiveness and Resource Allocation : C/E|September 23, 2021
Avoiding health technology assessment: a global survey of reasons for not using health technology assessment in decision makingYot Teerawattananon, Chris Painter, Saudamini Dabak, et al.
Pageof 15

Showing results (91-100 of 150) with videos related to

Sort By:
Pageof 15
Pharmacoeconomics|August 23, 2014
Healthy decisions: towards uncertainty tolerance in healthcare policyJanneke P C Grutters, Marjolein B A van Asselt, Kalipso Chalkidou, et al.
BMJ Global Health|October 27, 2018
Mind the costs, too: towards better cost-effectiveness analyses of PBF programmesY-Ling Chi, Mohamed Gad, Sebastian Bauhoff, et al.
The Milbank Quarterly|June 16, 2009
Comparative effectiveness research and evidence-based health policy: experience from four countriesKalipso Chalkidou, Sean Tunis, Ruth Lopert, et al.
International Journal of Health Policy and Management|January 23, 2022
Developing a How-to-Guide for Health Technology Reassessment: "The HTR Playbook"Lesley J J Soril, Adam G Elshaug, Rosmin Esmail, et al.
Gates Open Research|October 22, 2019
How can we make better health decisions a Best Buy for all?: Commentary based on discussions at iDSI roundtable on 2 <sup>nd</sup> May 2019 London, UKNiki O'Brien, Ryan Li, Wanrudee Isaranuwatchai, et al.
European Journal of Cancer (Oxford, England : 1990)|May 29, 2021
Economic impact of avoidable cancer deaths caused by diagnostic delay during the COVID-19 pandemic: A national population-based modelling study in England, UKAdrian Gheorghe, Camille Maringe, James Spice, et al.
Global Heart|February 19, 2015
Priority-setting institutions in health: recommendations from a center for global development working groupAmanda Glassman, Kalipso Chalkidou, Ursula Giedion, et al.
The Lancet. Oncology|February 19, 2014
Evidence-informed frameworks for cost-effective cancer care and prevention in low, middle, and high-income countriesKalipso Chalkidou, Patricio Marquez, Preet K Dhillon, et al.
Frontiers in Public Health|September 13, 2021
An Introduction to the Main Types of Economic Evaluations Used for Informing Priority Setting and Resource Allocation in Healthcare: Key Features, Uses, and LimitationsHugo C Turner, Rachel A Archer, Laura E Downey, et al.
Cost Effectiveness and Resource Allocation : C/E|September 23, 2021
Avoiding health technology assessment: a global survey of reasons for not using health technology assessment in decision makingYot Teerawattananon, Chris Painter, Saudamini Dabak, et al.
Pageof 15